Frankfurt - Delayed Quote EUR
Adverum Biotechnologies, Inc. (AVU0.F)
2.5000
-0.0200
(-0.79%)
At close: April 29 at 8:06:32 AM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| FISCHER LAURENT D M.D. Chief Executive Officer | Stock Award(Grant) | Feb 25, 2025 | 96,614 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 23, 2025 | -- |
| LUPHER MARK L. JR., PH.D. Director | Purchase | Feb 7, 2024 | -- |
| OZDEN RABIA GURSES Officer | Stock Award(Grant) | Feb 25, 2025 | 8,125 |
| RUBINSTEIN LINDA M. Chief Financial Officer | Stock Award(Grant) | Feb 25, 2025 | 19,325 |
| SCOPA JAMES PAUL Director | Purchase | Feb 7, 2024 | 103,334 |
| SEYEDKAZEMI SETAREH Officer | Stock Award(Grant) | Feb 25, 2025 | 14,692 |
| SOPARKAR PETER Chief Operating Officer | Stock Award(Grant) | Feb 25, 2025 | 42,114 |
Related Tickers
1JK.F Apellis Pharmaceuticals, Inc.
15.14
+3.73%
1T3.F Syndax Pharmaceuticals, Inc.
11.50
+0.88%
F6T.F Fate Therapeutics, Inc.
1.0760
-2.09%
THRD Third Harmonic Bio, Inc.
5.15
0.00%
SION Sionna Therapeutics, Inc.
12.04
0.00%
UPB Upstream Bio, Inc.
8.98
+2.28%
FULC Fulcrum Therapeutics, Inc.
3.6500
+2.24%
TENX Tenax Therapeutics, Inc.
5.67
-3.66%
KYTX Kyverna Therapeutics, Inc.
2.0400
-0.49%
SNDX Syndax Pharmaceuticals, Inc.
13.70
+2.09%